13,904 research outputs found

    Attribute Identification and Predictive Customisation Using Fuzzy Clustering and Genetic Search for Industry 4.0 Environments

    Get PDF
    Today®s factory involves more services and customisation. A paradigm shift is towards “Industry 4.0” (i4) aiming at realising mass customisation at a mass production cost. However, there is a lack of tools for customer informatics. This paper addresses this issue and develops a predictive analytics framework integrating big data analysis and business informatics, using Computational Intelligence (CI). In particular, a fuzzy c-means is used for pattern recognition, as well as managing relevant big data for feeding potential customer needs and wants for improved productivity at the design stage for customised mass production. The selection of patterns from big data is performed using a genetic algorithm with fuzzy c-means, which helps with clustering and selection of optimal attributes. The case study shows that fuzzy c-means are able to assign new clusters with growing knowledge of customer needs and wants. The dataset has three types of entities: specification of various characteristics, assigned insurance risk rating, and normalised losses in use compared with other cars. The fuzzy c-means tool offers a number of features suitable for smart designs for an i4 environment

    The role of supply chain integration in achieving competitive advantage: A study of UK automobile manufacturers

    Get PDF
    The competitive nature of the global automobile industry has resulted in a battle for efficiency and consistency in supply chain management (SCM). For manufacturers, the diversified network of suppliers represents more than just a production system; it is a strategic asset that must be managed, evaluated, and revised in order to attain competitive advantage. One capability that has become an increasingly essential means of alignment and assessment is supply chain integration (SCI). Through such practices, manufacturers create informational capital that is inimitable, yet transferrable, allowing suppliers to participate in a mutually-beneficial system of performance-centred outcomes. From cost reduction to time improvements to quality control, the benefits of SCI extend throughout the supply chain lifecycle, providing firms with improved predictability, flexibility, and responsiveness. Yet in spite of such benefits, key limitations including exposure to risks, supplier failures, or changing competitive conditions may expose manufacturers to a vulnerable position that can severely impact value and performance. The current study summarizes the perspectives and predictions of managers within the automobile industry in the UK, highlighting a dynamic model of interdependency and interpolation that embraces SCI as a strategic resource. Full commitment to integration is critical to achieving improved outcomes and performance; therefore, firms seeking to integrate throughout their extended supply chain must be willing to embrace a less centralized locus of control

    Overview of Remaining Useful Life prediction techniques in Through-life Engineering Services

    Get PDF
    Through-life Engineering Services (TES) are essential in the manufacture and servicing of complex engineering products. TES improves support services by providing prognosis of run-to-failure and time-to-failure on-demand data for better decision making. The concept of Remaining Useful Life (RUL) is utilised to predict life-span of components (of a service system) with the purpose of minimising catastrophic failure events in both manufacturing and service sectors. The purpose of this paper is to identify failure mechanisms and emphasise the failure events prediction approaches that can effectively reduce uncertainties. It will demonstrate the classification of techniques used in RUL prediction for optimisation of products’ future use based on current products in-service with regards to predictability, availability and reliability. It presents a mapping of degradation mechanisms against techniques for knowledge acquisition with the objective of presenting to designers and manufacturers ways to improve the life-span of components

    Lifecycle management of process analytical methods for pharmaceuticals quality control

    Get PDF
    Trabalho Final de Mestrado Integrado, CiĂȘncias FarmacĂȘuticas, 2022, Universidade de Lisboa, Faculdade de FarmĂĄcia.A esperança mĂ©dia de vida da população mundial, tem aumentado bastante nos Ășltimos cem anos e isto, deve-se ao facto das novas descobertas na medicina, principalmente as descobertas de novas substĂąncias ativas que ajudam a combater patologias que jĂĄ existiam ou novas que vĂŁo aparecendo. Com isto, houve um grande crescimento do mercado de medicamentos, pois estes permitem que algumas pessoas com condiçÔes mĂ©dicas debilitadas mantenham a qualidade de vida, apesar do quadro clĂ­nico. Contudo os medicamentos, tambĂ©m tĂȘm reaçÔes adversas que podem prejudicar a qualidade de vida dos doentes e, para minimizar esta situação, Ă© necessĂĄrio supervisionar e garantir a qualidade dos produtos farmacĂȘuticos. Consequentemente, em 1994 foi criada e terminada em 1996, a International Council for Harmonisation Quality Guideline 2 – Validação de Procedimentos AnalĂ­ticos, com o intuito de conseguir validar novos procedimentos analĂ­ticos ou que jĂĄ existiam, avaliando ensaios, impurezas, potĂȘncia e qualquer outra medida quantitativa ou qualitativa. Garantindo que os medicamentos sĂŁo seguros para o consumo dos doentes, fazendo assim um controlo estratĂ©gico do benefĂ­cio-risco do medicamento ou da substĂąncia ativa. Todavia, com o passar dos anos, com o aumento da tecnologia e dos mĂ©todos analĂ­ticos, esta diretriz foi revelando algumas limitaçÔes, nĂŁo sendo adequada para alguns mĂ©todos analĂ­ticos que foram surgindo recentemente. Por isso, foi necessĂĄrio criar uma nova diretriz que conseguisse abranger todos estes novos mĂ©todos e, posto isso, em 2022, foi apresentado o texto provisĂłrio da International Council for Harmonisation Quality Guideline 14 – Desenvolvimento de Procedimentos AnalĂ­ticos. Esta diretriz tem como objetivo conseguir regular o desenvolvimento de novos mĂ©todos analĂ­ticos, para que se melhore a comunicação entre a indĂșstria farmacĂȘutica e agĂȘncias reguladoras. No entanto, esta nova diretriz, no seu texto atual encontra-se em vĂĄrios aspetos incompleta, vaga, com falta de consistĂȘncia na informação do documento e confusa, sendo necessĂĄrio uma revisĂŁo do documento na Ă­ntegra, para que seja um acrĂ©scimo real relativamente Ă  diretriz existente (ICH Q2).The average life expectation of the world population has increased significantly in the last hundred years, and this is due to the fact of new discoveries in medicine, mainly as discoveries of new active substances that help to fight pathologies that already existed or new ones that are appearing. With this, there was a great growth in the drug market, as they allow some people with debilitated medical conditions to maintain their quality of life, despite their clinical condition. However, medicines also have adverse reactions that can impair the quality of life of patients and, to minimize this situation, it is also necessary to supervise and guarantee the quality of pharmaceutical products. Consequently, in 1994, the International Council for Harmonization Quality Guideline 2 – Validation of Analytical Procedures was created and ended in 1996, in order to validate new or existing analytical procedures, evaluating tests, impurities, potency and any other quantitative or qualitative measurement. Ensuring that medicines are safe for patients to consume, thus making a strategic control of the benefit-risk of the medicine or active substance. However, over the years, with the increase in technology and analytical methods, this guideline has revealed some limitations, not being suitable for some analytical methods that have emerged recently. Therefore, it was necessary to create a new guideline that could cover all these new methods and, therefore, in 2022, the provisional text of the International Council for Harmonization Quality Guideline 14 – Development of Analytical Procedures was presented. This guideline aims to regulate the development of new analytical methods, in order to improve communication between the pharmaceutical industry and regulatory agencies. Nevertheless, this new guideline, in its current text, is incomplete, vague, with a lack of consistency in the information in the document and confusing, requiring a revision of the document in its entirety, so that it is a real addition to the guideline existing (ICH-Q2)

    Digital Twin Technology

    Get PDF
    Digital twin technology is considered to be the core technology of realizing Cyber-Physical System (CPS). It is the simulation technology that integrates multidisciplinary, multiphysical quantity, multiscale and multi probability by making full use of physical model, sensor update, operation history and other data. It is the mapping technology for the whole lifecycle process of physical equipment in virtual space. It is the basic technology of Industrial 4.0. This chapter mainly introduces: (1) the generation of digital twin technology; (2) the definition and characteristics of digital twin technology; (3) the relationship between digital twin and digital thread; (4) the implementation of the product digital twin model; and (5) the research progress and application of digital twin research

    Local Digital Twin-based control of a cobot-assisted assembly cell based on Dispatching Rules

    Get PDF
    In the context of an increasing digitalization of production processes, Digital Twins (DT) are emerging as new simulation paradigm for manufacturing, which leads to potential advances in the production planning and control of production systems. In particular, DT can support production control activities thanks to the bidirectional connection in near real-time with the modeled system. Research on DT for production planning and control of automated systems is already ongoing, but manual and semi-manual systems did not receive the same attention. In this paper, a novel framework focused on a local DT is proposed to control a cobot-assisted assembly cell. The DT replicates the behavior of the cell, providing accurate predictions of its performances in alternative scenarios. Then, building on these predicted estimates, the controller selects, among different dispatching rules, the most appropriate one to pursue different performance objectives. This has been proven beneficial through a simulation assessment of the whole assembly line considered as testbed

    ARMD Workshop on Materials and Methods for Rapid Manufacturing for Commercial and Urban Aviation

    Get PDF
    This report documents the goals, organization and outcomes of the NASA Aeronautics Research Mission Directorates (ARMD) Materials and Methods for Rapid Manufacturing for Commercial and Urban Aviation Workshop. The workshop began with a series of plenary presentations by leaders in the field of structures and materials, followed by concurrent symposia focused on forecasting the future of various technologies related to rapid manufacturing of metallic materials and polymeric matrix composites, referred to herein as composites. Shortly after the workshop, questionnaires were sent to key workshop participants from the aerospace industry with requests to rank the importance of a series of potential investment areas identified during the workshop. Outcomes from the workshop and subsequent questionnaires are being used as guidance for NASA investments in this important technology area
    • 

    corecore